Key Points Pfizer’s earnings and stock price soared in early pandemic days thanks to its coronavirus treatment and ...

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Shares of this ...

PFE’s Stock Performance, Rising Estimates & Attractive Valuation. Pfizer’s stock has declined 6.9% in the past year compared with a decrease of 1.6% for the industry.

Pfizer (PFE) concluded the recent trading session at $25.35, signifying a -1.17% move from its prior day's close.

Firstly, let us look at Pfizer’s stock performance in recent years. PFE stock has faced a notable decline of 30% from levels of $35 in early January 2021 to around $25 now, vs. an increase of ...

Firstly, let us look at Pfizer’s stock performance. PFE stock has seen a decline of 15% from levels of $35 in early January 2021 to around $30 now, vs. an increase of about 35% for the S&P 500 ...

That didn't help Pfizer's share performance this year, though. The stock has slipped about 35%. ... If You'd Invested $10,000 in Pfizer Stock 10 Years Ago, Here's How Much You'd Have Today.

When I saw Pfizer Inc. stock settling below pre-pandemic levels, I knew the deterioration of investor sentiment has a lot to do with declining Covid vaccine sales. This was expected. A deep dive ...

Pfizer's recent financial performance shows 14% YoY operational growth excluding COVID sales. Check out more on PFE stock here.